TB Disease Prevalence Survey - Progress Report

Similar documents
TB Disease Prevalence Survey - Overview and Introduction of the TF

TB Disease Prevalence Survey - Overview, why and how

WHO Global Task Force on TB Impact Measurement An overview

Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB

National TB prevalence surveys

Global TB control: Current status with particular attention to TB among women and children

Subgroup Report Prevalence Survey. Ikushi Onozaki WHO/HQ/HTM/STB/TBS

GLOBAL TB IMPACT MEASUREMENT

BACKGROUND DOCUMENT 4e. Prevalence surveys of TB disease post-2015 Why, How, Where?

Appendix 3 Sample size and cost of surveys

What is this document and who is it for?

Investing for Impact

Global reductions in measles mortality and the risk of measles resurgence

Annex 2 A. Regional profile: West Africa

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance

Outline. Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications

Landscape Analysis on Countries' Readiness to Accelerate Action to Reduce Maternal and Child Undernutrition

JOINT TB AND HIV PROGRAMMING

O c t o b e r 1 0,

TB, BCG and other things. Chris Conlon Infectious Diseases Oxford

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

FP2020 Expert Advisory Community Webinar

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

GBD2013 Tuberculosis estimates of mortality, incidence and prevalence

The epidemiology of tuberculosis

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health

National tuberculosis prevalence surveys in Asia, : an overview of results and lessons learned

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

TT Procured by UNICEF

Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer

Impact Dashboard - October 2014

Background paper number 7

Impact Dashboard - August 2014

Strengthening Lab Capacity for TB Diagnosis and Care in LMICs

Humanitarian Initiative to Prepare for a Pandemic Influenza Emergency (HIPPIE) Ron Waldman, MD Avian and Pandemic Influenza Unit USAID/Washington

Comparative Analyses of Adolescent Nutrition Indicators

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

La Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012

Eligibility List 2018

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

Toshihiko Osawa World Customs Organization

Technology and innovation: Changing dynamics of TB control. Karin Weyer

Global, National, Regional

Experiences on Workforce Development in Other Regions

Epidemiology and economics: modelling the scenarios for the end of AIDS

ON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Mathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & James Seddon (Imperial College London)

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY

AIDS Funding Landscape in Asia and the Pacific

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010

Potentials for Integrating CVD Surveillance and HIV Surveillance

Recipients of development assistance for health

HPV Vaccine Lessons Learned & New Ways Forward

Finding the missing TB cases

EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN

The Goals Model as a Tool for Allocating HIV/AIDS Resources & Strategic Planning

TB surveillance and surveys: A training workshop for consultants Chateau de Penthes, Geneva May 2011

Child undernutrition based on the new WHO growth standards and rates of reduction to 2015

Putting the recommendations into action

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016

Global Measles and Rubella Update. April 2018

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Report of WS on Prevalence Survey in Beijing. Norio Yamada RIT/JATA

Mobile clinic services will be provided along with a campaign for long term and new methods of family planning in Afghanistan

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

UNAIDS 2013 AIDS by the numbers

Global Measles and Rubella Update November 2018

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Barriers to Global TB Control. Carol D. Hamilton, MD, MHS Director, Scientific Affairs FHI 360 Professor of Medicine, Duke University

Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

World Health Organization 2013

Prioritizing Emergency Polio Eradication Activities

WHAT'S IN A NUMBER? TWO RECENT REPORTS ESTIMATING CHILDHOOD TB CASES.

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

HIV Prevention in Young People: Current Context, Opportunities and Challenges Dr. Susan Kasedde Senior Specialist, HIV Prevention UNICEF, NY

Global Fund ARV Fact Sheet 1 st June, 2009

Why is Medicine Quality Important?

Ending the AIDS Epidemic in Adolescents

REVIEW OF TUBERCULOSIS EPIDEMIOLOGY

Global, National, Regional

The first National TB Prevalence Survey Rwanda 2012

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030

MATERNAL, NEWBORN, AND CHILD HEALTH

ASLM Building laboratory capacity in Africa in a sustainable way

Evaluating the acceptability of vaccine and vaccination programmes: an individual and public health perspective

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

AIDS in Africa. An Update. Basil Reekie

Transcription:

TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

Back Ground: 3 strategic areas of work of the WHO Global Task Force on TB Impact Measurement (Dec 2007) Strengthening surveillance use of routine surveillance data to measure incidence, prevalence and mortality all countries ultimate goal to measure cases and deaths directly from notification and vital registration data Prevalence of TB disease surveys in 21 global focus countries Periodic review and revision of methods used to translate data from surveillance systems and surveys into estimates of disease burden

The Task Force Work since 2008 Set a global guidance for standardization Lime Book Assist Countries Feasibility assessment Preparation & in country sensitization Workshops: Study design & Budgeting Protocol Review Coordination of Technical Assistance Survey Operation Review Analysis Certificate the study Training (Survey managers, Consultants) Provide data for Re estimation of TB Burden Global Advocacy & Fund raising

Achievement and Plan 8 Global progress with nationwide prevalence surveys of TB disease Myanmar Number of surveys 6 4 2 21 Global Focus countries selected by Task Force Viet Nam Pakistan Lao PDR Ethiopia China Thailand Tanzania Malawi Rwanda Nigeria Bangladesh Viet Nam Philippines Uganda Nepal The Gambia Mozambique South Africa Indonesia 0 Cambodia Malaysia Indonesia Eritrea Thailand Philippines Bangladesh Myanmar Cambodia Ghana Kenya Zambia 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 15 Asia Africa Non Global Focus country As shown in the last progress report in 2010 4

Progress in Countries 5

A. Countries Reporting Survey Results Bangladesh ( 2007 09) Publish the results in a peer review journal Myanmar (2009 10) Final Report to be published: Burden higher than expected China (2010) FinalReport to be published : Showing significant decline of bacteriologically confirmed cases Ethiopia (2010 11) Preliminary Results First National Survey in Africa in 50 years along WHO guidelines (with CXR screening and culture diagnosis) Note: Philippines and Vietnam ( 2007) have published the results in peer review journals, planning a repeat survey by 2015

B. Countries completing the surveys in 2011 Cambodia A first repeat survey under DOTS (2002 2011) Impact and limitation of quality DOTS programme Contribution to surveys of other countries and WHO training courses Pakistan Successful Field Operation in spite of lots of challenges Laos* Showing much higher TB burden *: Non Global Focus Countries

C. Countries completing a pilot and/or launching a survey in 2011 Nigeria Thailand Tanzania Rwanda Gambia*

D. Countries preparing to launch a survey in 2012 Ghana Malawi Kenya South Africa Indonesia Uganda We will have much clearer vision of TB Epidemiological Situations in Africa Funding is basically approved and a revised protocol has been submitted to the Task Force Review; Procurement is the biggest challenge in most of the countries

E. Other countries showing interests Sierra Leone Zambia Mali Nepal* Sudan* Eretria* Botswana* India* Others

Characteristics of 20 surveys in pipelines since 2007 Multistage Cluster Sampling by PPS with 2 3 Strata (Most) Sample Size: 40,000 60,000 (10 surveys) > 100,000: China, Pakistan and Viet Nam Cluster Size: 500 800 (12 surveys) Age: > 15 years old (19 surveys) Screening methodology: Interview (symptom) + CXR: 18 surveys Diagnosis: Smear and Culture (19 surveys)

Characteristics of Surveys Smear: Introduction of LED Fluorescent microscopy Culture: No successful survey with Liquid Media yet due to logistic challenge high contamination (5 7 days to inoculate after the collection) CXR: Onsite reading: Direct CXR (Auto processor or Digital CR or DR) Any abnormality in lung (most) Symptom screening: NTP definition of TB suspects (most) or combination of additional symptoms in high HIV setting HIV Testing only detected TB cases by routine offer by the program (most)

What we measure and what we learn Size of the burden (prevalence) and its change Self Cure Incident Cases TB Cases in the Community Cure by Treatment Death

Size: often larger in Asia Self Cure Incident Cases TB Cases in the Community 3 4 times or more than the cases under treatment (Double of annual notification) Cure by Treatment Death

When it is smaller, critical assessment on screening and diagnostic measures are more essential Ethiopia, Bangladesh Self Cure Incident Cases TB Cases in the Community Cure by Treatment Death

More lessons than expected PREVALENT TB CASES Impact of DOTS: removing Chronic Cases from the community KNOWN KNOWN

Presence of Symptoms Limitations of Current Screening Strategies Symp+ Symp +

Bacteriological Status Culture Positive Limitations of Current Diagnostic Tools Smear+ Smear+

Size, Behaviour and Practice of Cases (or suspects) Including those outside the NTP Self Cure Incident Cases TB Cases in the Community Cure by Treatment Death

Where are they treated? Notified Notified ON Treatment Notnotified + + Notnotified GPs, Large hospitals, informal sector

Risks and predictive factors Who are more likely to have TB Self Cure Incident Cases TB Cases in the Community Cure by Treatment Poor, smokers, residents in remote areas or urban congestive areas, elders, young adults, mobile populations, Chest X ray abnormal???????? Death

Achievements and Challenges More accurate estimation of the burden Understandings on the gap with the surveillance data Policy implications Challenges Limitations Limited capacity of Culture Lab TB in Children (and extra pulmonary) Introduction of new technologies molecular, digital.

The Way Forward Past 3 years Introductory Seminar Workshop on Survey Design and Preparation Workshop and Seminar on Survey Operation and Management Training for country coordinators and consultants Now Countries Rather comfortable with field work, while straggling with data management, culture and analysis Country Country collaboration Support on Data management and Analysis Tomorrow Repeat survey design Policy Implications

Summary Since 2008, massive efforts were done to standardize a country survey and to assist countries 20 countries are in pipelines and a few others showing interests Asia keeps on track to measure changes of TB epidemiology towards the MDGs Ethiopia completed the 1 st survey in Africa in five decades under the task force support TB situation in Africa will be much clearer when at least 5 6 countries will complete a survey in 2012 Countries and world began to learn implications to the program much more than expected: A quality survey can tell more than prevalence Appropriate design and analysis are essential to measure change (and/or impact) by surveys around 2015